tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Gregory Renza, 369 are a BUY (85.22%), 64 are a HOLD (14.78%).
Analyst Gregory Renza, currently employed at TRUIST, carries an average stock price target met ratio of 47.95% that have a potential upside of 44.63% achieved within 185 days. Previously, Gregory Renza worked at RBC.
Gregory Renza’s has documented 838 price targets and ratings displayed on 47 stocks. The coverage is on Healthcare, Consumer Defensive sectors.
Most recent stock forecast was given on AGIO, Agios Pharm.
Analyst best performing recommendations are on RXDX (PROMETHEUS BIOSCIENCES).
The best stock recommendation documented was for RXDX (PROMETHEUS BIOSCIENCES) at 12/7/2022. The price target of $111 was fulfilled within 1 day with a profit of $15.2 (15.87%) receiving and performance score of 158.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 22-Jun-2022
$38
$16.53 (76.99%)
$36
Buy Since 23-Jun-2025
$38
$16.53 (76.99%)
$36
Buy Since 28-Feb-2024
$35
$13.53 (63.02%)
$35
22 days ago
(19-Oct-2026)
9/16 (56.25%)
$15.2 (76.77%)
393
Buy Since 15-Dec-2025
$33
$11.53 (53.70%)
$37
1 months 16 days ago
(25-Sep-2026)
0/3 (0%)
$12.32 (59.57%)
Buy Since 17-Apr-2025
$34
$12.53 (58.36%)
$36
1 months 16 days ago
(25-Sep-2026)
4/6 (66.67%)
$13.32 (64.41%)
144
Which stock is Gregory Renza most bullish on?
Which stock is Gregory Renza most reserved on?
What Year was the first public recommendation made by Gregory Renza?
